Detalles de la búsqueda
1.
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.
Gastroenterology
; 158(8): 2180-2194, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147484
2.
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
Gastroenterology
; 159(2): 521-533.e9, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343960
3.
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy.
J Viral Hepat
; 28(5): 817-825, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556206
4.
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
Hepatol Commun
; 6(8): 1870-1880, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368148
5.
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.
Hepatol Commun
; 5(11): 1873-1887, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558823
Resultados
1 -
5
de 5
1
Próxima >
>>